News
Luminopia's amblyopia treatment now includes patients aged 8 to 12, expanding its previous FDA approval for ages 4 to 7. The ...
The OcuMet Beacon is a proprietary, noninvasive tool for assessing retinal health. The company said it will be available on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback